— Know what they know.
Not Investment Advice
Also trades as: 1666.HK (HKSE) · $vol 1M

TGRNF OTC

Tong Ren Tang Technologies Co. Ltd.
1W: +0.0% 1M: -19.3% 3M: -19.3% YTD: -43.0% 1Y: -43.0% 3Y: -49.1% 5Y: -22.2%
$0.40
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 39 · $511.3M mcap · 585M float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$16M -97.2% ▼
5Y CAGR: -56.9%
Capital Expenditures
$174M -68.4% ▼
5Y CAGR: -3.7%
Free Cash Flow
-$159M -135.2% ▼
Dividends Paid
$228M -12.5% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
$1.4B +241.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$468M$507M$583M$590M$1.1B
Depreciation & Amort.$270M$250M$262M$277M$290M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$399M-$415M-$703M-$1.1B-$1.1B
Other Non-Cash Items$97M$692M$582M$810M-$275M
Operating Cash Flow$436M$1.0B$724M$554M$16M
— Investing Activities —
Capital Expenditures-$546M-$156M-$158M-$103M-$174M
Acquisitions (Net)-$437M-$12M-$177M$0-$35M
Investment Purchases-$518M-$503M-$326M$0-$43M
Investment Sales$955M$454M$503M$0$1.3B
Other Investing$350M$20M$201M-$964M$46M
Investing Cash Flow-$195M-$197M$43M-$1.1B$1.0B
— Financing Activities —
Net Debt Issuance$130M-$99M-$90M-$93M$798M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$205M-$205M-$205M-$203M-$228M
Other Financing-$89M-$170M-$204M-$202M-$282M
Financing Cash Flow-$165M-$475M-$499M-$498M$288M
Net Change in Cash-$43M$298M$476M-$975M$1.4B
Cash End of Period$2.9B$3.2B$3.7B$2.7B$4.1B
Free Cash Flow-$110M$877M$566M$451M-$159M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms